Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1624 1626
This examiner grants 68% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18706551 | USES OF RHODOQUINONE FOR THE TREATMENT OF DISEASE | Non-Final OA | University of Massachusetts |
| 18558812 | CO-CRYSTAL OF MELANOCORTIN RECEPTOR AGONIST COMPOUND AND VANILLIN AND METHOD FOR PREPARING SAME | Non-Final OA | LG CHEM, LTD. |
| 17934553 | 3-(ANILINO)-2-[3-(3-ALKOXY-PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER | Non-Final OA | Dana-Farber Cancer Institute, Inc. |
| 17605956 | 4H-PYRROLO[3,2-c]PYRIDIN-4-ONE COMPOUNDS | Final Rejection | Dana-Farber Cancer Institute, Inc. |
| 17425119 | METHODS OF CONTROLLING OR PREVENTING INFESTATION OF CORN PLANTS BY PHYTOPATHOGENIC MICROORGANISMS | Non-Final OA | SYNGENTA CROP PROTECTION AG |
| 17265333 | ADJUVANT EFFECT OF THE TLR1/2 AGONIST DIPROVOCIM SYNERGIZES WITH CHECKPOINT-INHIBITING ANTIBODIES TO ELIMINATE DISEASE | Final Rejection | The Board of Regents of the University of Texas System |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy